Description
The vegetable-based slow-release capsules are designed to dissolve later, and bypass the stomach to the gut, withstanding stomach acids, where the healthy bacteria can perform its functions. This allows the probiotics inside to be unaffected by other substances.
Exposure to the stomach acids will result in the probiotics being destroyed and not establishing itself in the gastrointestinal tract, which will render consuming YourGutPlus+ ineffective.
(Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909163/)
YourGutPlus+ contains multi-strain, scientifically tested, lactobacillus probiotics which are non-dairy. These help to break down healthy foods and nourish the gut lining cells, maintaining a healthy gut wall.
Each capsule contains 10 times the amount of natural bacteria as a large yogurt. It is also supported by an effective prebiotic soluble fibre, inulin which aids the gut microbiome. There’s no recommended amount of probiotics one should consume daily. Most numbers vary from 1 to 10 billion that you can consume once or twice daily. A lack of probiotics might hinder your progress. However, this doesn’t mean consuming more is the best option.
Backed by reputable British research, we assure safety and efficacy. The supplements featured are produced by established British manufacturers in compliance with international standards and examined extensively by the British ethics committee and the Medicines and Healthcare products Regulatory Agency (MHRA). During the UK trial, no side effects were found among participants.
YourGutPlus+ contains the recommended dietary allowance of vitamin D, making it redundant to consume extra vitamin D supplements. Coupled with probiotics, vitamin D significantly improves absorption, bioavailability and health functions.
YourGutPlus+ was developed and tested for Phyto-v, a UK national intervention study, in May 2020. There’s also been a paper published about it in the open access journal, Infectious Diseases Diagnosis & Treatment. Research and development of the supplement was conducted by renowned oncologist Professor Robert Thomas, and funded by the UK government. Professor Thomas was voted by the British Oncology Association as Oncologist of the Year as well as Hospital Doctor Magazine’s Doctor of the Year. He has also won the NHS Communications Research Award and the Royal College Frank Ellis Medal.
